Amy Schumer has revealed that abuse from internet trolls about her appearance caused her to be diagnosed with a condition called Cushing syndrome. In the “News Not Noise” letter published on 23 ...

Add Yahoo as a preferred source to see more of our stories on Google. Schumer shared in the News Not Noise newsletter late last week, that she has exogenous Cushing syndrome that was brought on by ...

After opening up about recent medical issues, Amy Schumer has revealed that she's been diagnosed with exogenous Cushing syndrome, a hormonal disorder caused by high levels of cortisol in the body. The ...

Please provide your email address to receive an email when new articles are posted on . Of adults who achieved Cushing’s disease remission after surgery, 10.4% developed new-onset autoimmune disease.

Dr. Donita McCants-Prepti, DVM, CPT, CNC, is a veterinarian, speaker, and advocate for whole-person well-being in veterinary medicine. She earned her Doctor of Veterinary Medicine degree from Tuskegee ...

It’s no wonder why dogs are man’s best friend—dogs and humans are very similar, with 84% genetic overlap. However, this also means that dogs may develop some of the same diseases we do, including ...

Patients with Cushing disease have an increased risk for new-onset autoimmune disease in the 3 years after surgical remission, according to a new retrospective study published on February 20 in Annals ...

Agents that directly lower ACTH secretion by a pituitary adenoma represent an attractive option for the treatment of Cushing's disease, as these drugs directly target the pathogenesis of disease.

Comedian Amy Schumer has long been open about the health battles she has faced, despite being no stranger to criticism and controversy. On Friday, Schumer revealed in an interview that she had been ...

Development of autoimmune disease was more common in patients with surgical remission of Cushing's disease than in those with surgically treated nonfunctioning pituitary adenomas (NFPAs), according to ...

The Food and Drug Administration (FDA) has approved Isturisa ® (osilodrostat) for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome for whom surgery is not an option or has ...